HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Brian I Carr Selected Research

gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)

6/2020Gamma glutamyl transpeptidase as a prognostic biomarker in hepatocellular cancer patients especially with >5 cm tumors, treated by liver transplantation.
1/2020Microscopic vascular invasion by hepatocellular carcinoma in liver transplant patients.
4/2018Analysis of aggressiveness factors in hepatocellular carcinoma patients undergoing transarterial chemoembolization.
9/2017Validation of a Liver Index and Its Significance for HCC Aggressiveness.
10/2016A Liver Index and its Relationship to Indices of HCC Aggressiveness.
12/2014Low alpha-fetoprotein HCC and the role of GGTP.
9/2014Significance of platelet and AFP levels and liver function parameters for HCC size and survival.
4/2014Association of abnormal plasma bilirubin with aggressive hepatocellular carcinoma phenotype.
1/2014Features of massive hepatocellular carcinomas.
1/2013Hepatocellular carcinoma size: platelets, γ-glutamyl transpeptidase, and alkaline phosphatase.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Brian I Carr Research Topics

Disease

82Neoplasms (Cancer)
01/2022 - 01/2002
78Hepatocellular Carcinoma (Hepatoma)
01/2022 - 01/2002
33Thrombosis (Thrombus)
01/2022 - 01/2007
14Fibrosis (Cirrhosis)
11/2018 - 11/2004
8Liver Neoplasms (Liver Cancer)
01/2021 - 09/2002
7Inflammation (Inflammations)
01/2021 - 08/2016
5Neoplasm Metastasis (Metastasis)
01/2022 - 06/2005
5Hepatitis
08/2012 - 02/2005
4Thrombocytopenia (Thrombopenia)
01/2018 - 01/2012
4Pancreatic Neoplasms (Pancreatic Cancer)
03/2012 - 04/2010
3Liver Diseases (Liver Disease)
01/2021 - 08/2012
3Fatigue
01/2013 - 09/2002
3Ascites
12/2009 - 01/2007
2Klatskin Tumor
12/2022 - 05/2022
2Infections
12/2021 - 04/2015
2Hepatitis B
01/2013 - 08/2012
2Adenocarcinoma
03/2012 - 07/2010
1Chronic Hepatitis B
12/2021
1Non-alcoholic Fatty Liver Disease
11/2018
1Thromboembolism
01/2018
1Liver Cirrhosis (Hepatic Cirrhosis)
01/2018
1Venous Thromboembolism
01/2018
1Alcoholism (Alcohol Abuse)
04/2015
1End Stage Liver Disease
11/2014
1Drug-Related Side Effects and Adverse Reactions
10/2013
1Thrombocytosis (Thrombocythemia)
06/2013

Drug/Important Bio-Agent (IBA)

28BilirubinIBA
12/2021 - 02/2005
28alpha-Fetoproteins (alpha-Fetoprotein)IBA
12/2021 - 11/2004
17gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA
06/2020 - 01/2007
12AlbuminsIBA
02/2021 - 01/2007
9Phosphotransferases (Kinase)IBA
01/2017 - 12/2002
9Sorafenib (BAY 43-9006)FDA Link
07/2015 - 07/2010
9VitaminsIBA
09/2011 - 02/2003
8Fetal Proteins (Fetoprotein)IBA
01/2018 - 01/2012
7YttriumIBA
08/2012 - 02/2005
6Pharmaceutical PreparationsIBA
01/2015 - 01/2008
6Vitamin KFDA Link
07/2010 - 01/2002
6DNA (Deoxyribonucleic Acid)IBA
10/2007 - 01/2002
5Biomarkers (Surrogate Marker)IBA
01/2022 - 05/2010
5C-Reactive ProteinIBA
06/2019 - 01/2017
5Alkaline PhosphataseIBA
01/2016 - 12/2009
5Growth InhibitorsIBA
01/2015 - 06/2006
4cdc25 PhosphatasesIBA
10/2008 - 05/2003
3Tumor Biomarkers (Tumor Markers)IBA
01/2019 - 01/2002
3acarboxyprothrombin (PIVKA)IBA
03/2016 - 03/2007
3Prothrombin (Factor II)IBA
01/2016 - 09/2007
3regorafenibIBA
05/2014 - 02/2013
3ErbB Receptors (EGF Receptor)IBA
03/2012 - 05/2002
3Phosphoric Monoester Hydrolases (Phosphatases)IBA
08/2010 - 11/2006
3Proteins (Proteins, Gene)FDA Link
04/2010 - 05/2003
3Vitamin K 3 (Menadione)FDA Link
10/2006 - 05/2003
3Yttrium-90IBA
02/2005 - 09/2002
3Protein Tyrosine PhosphatasesIBA
09/2003 - 08/2002
26-propylchromone-2-carboxylic acid (PCCA)IBA
12/2022 - 05/2022
2LipidsIBA
01/2022 - 11/2018
2HDL CholesterolIBA
01/2022 - 11/2018
2Serum AlbuminIBA
10/2017 - 01/2017
2Indicators and Reagents (Reagents)IBA
01/2017 - 03/2007
2EnzymesIBA
01/2016 - 09/2002
2Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
07/2015 - 07/2010
2Biological ProductsIBA
04/2015 - 04/2005
2Cisplatin (Platino)FDA LinkGeneric
09/2010 - 01/2008
2GemcitabineFDA Link
09/2010 - 01/2008
2CaspasesIBA
04/2010 - 09/2005
2RTA 502IBA
10/2009 - 04/2009
2Phosphoprotein Phosphatases (Phosphatases, Protein)IBA
10/2009 - 06/2005
2Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
12/2007 - 06/2005
2Fibronectins (Fibronectin)IBA
10/2007 - 09/2007
1BismuthIBA
05/2022
1entecavirFDA Link
12/2021
1Tenofovir (Viread)FDA Link
12/2021
1Antiviral Agents (Antivirals)IBA
12/2021
1Transaminases (Aminotransferases)IBA
01/2021
1TransferasesIBA
12/2020
1SirtuinsIBA
01/2019
1LDL CholesterolIBA
11/2018
1Lipoproteins (Lipoprotein)IBA
11/2018
1Triglycerides (Triacylglycerol)IBA
11/2018
1CholesterolIBA
11/2018
1Heparin (Liquaemin)FDA LinkGeneric
01/2018
1Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
01/2018
1Mitochondrial DNA (mtDNA)IBA
08/2016
1Glutamine (L-Glutamine)FDA Link
08/2016
1Angiotensin II Type 1 Receptor BlockersIBA
11/2015
1Angiotensin Receptors (Angiotensin II Receptor)IBA
11/2015
1Angiotensin IIIBA
11/2015
1Aflatoxin B1 (Aflatoxin B)IBA
04/2015
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2015
1Ferritins (Ferritin)IBA
11/2014
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
06/2014
1Aspartic Acid (Aspartate)FDA Link
06/2014
1Doxorubicin (Adriamycin)FDA LinkGeneric
01/2014

Therapy/Procedure

25Therapeutics
12/2021 - 09/2002
17Liver Transplantation
12/2022 - 11/2004
12Microspheres (Microsphere)
03/2012 - 09/2002
7Drug Therapy (Chemotherapy)
01/2015 - 01/2002
4Radiotherapy
08/2012 - 09/2002
3Aftercare (After-Treatment)
01/2020 - 07/2005
3Radiofrequency Ablation
11/2015 - 11/2014
3Palliative Care (Palliative Therapy)
03/2013 - 07/2005